Pre-menstrual syndrome (PMS) is defined as a condition that affects women at childbearing age and is characterized by symptoms such as bloating, pain, breast tenderness, body pain, fatigue, mood fluctuation, anxiety, etc.
This report contains market size and forecasts of Pre-Menstrual Syndrome in Global, including the following market information:
Global Pre-Menstrual Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pre-Menstrual Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Analgesics (Pain Killers) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pre-Menstrual Syndrome include Alva-Amco Pharmacal Cos., Inc., Bayer, Inc., Chattem, Inc. (Sanofi), DEKK-TEC, Inc., G. R. Lane Health Products Ltd, McNeil Consumer Healthcare, MetP Pharma AG, Pherin Pharmaceuticals, Inc. and Umecrine Mood AB, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pre-Menstrual Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pre-Menstrual Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pre-Menstrual Syndrome Market Segment Percentages, by Type, 2021 (%)
Analgesics (Pain Killers)
Oral Contraceptive Pills (OCPs)
Gonadotropin-Releasing Hormone (GnRH)
Antidepressants
Ovarian Suppressors
Diuretics
Benzodiazepines
Global Pre-Menstrual Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pre-Menstrual Syndrome Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Pre-Menstrual Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pre-Menstrual Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pre-Menstrual Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pre-Menstrual Syndrome revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alva-Amco Pharmacal Cos., Inc.
Bayer, Inc.
Chattem, Inc. (Sanofi)
DEKK-TEC, Inc.
G. R. Lane Health Products Ltd
McNeil Consumer Healthcare
MetP Pharma AG
Pherin Pharmaceuticals, Inc.
Umecrine Mood AB
Novartis AG
GlaxoSmithKline Plc